Paper Review Records
全部论文审稿周期
21 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
163
天
Concurrent Schistosoma mansoni infection suppresses induction of HIV-1 Env-specific antibodies in a DNA-MVA-gp140 Env vaccine regimen in rhesus macaques
作者
Gerald K. Chege; Rosamund E. Chapman; Asisipho Mzukwa; Alana T. Keyser; Craig H. Adams; Michiel T. van Diepen; Nicola Douglass; Nonkululeko Mzindle; Qiniso Mkhize; Penny L. Moore; Anna-Lise Williamson展开收起
作者单位
1. South African Medical Research Council; 2. University of Cape Town; 3. University of the Witwatersrand; 4. A Division of the National Health Laboratory Service; 5. University of KwaZulu-Natal展开收起
144
天
Vaccination coverage, dropout and predictors of schedule-complete vaccination among children aged 0–59 months in Gushegu and Nanumba South districts, northern Ghana: A cross-sectional study
作者
Matthew Konlan; Rajan Bhandari; Hilarius Asiwome Kosi Abiwu; Sheila Agyeiwaa Owusu; Amos Nunifant; Sheryl Weyere Adongo; Michael Rockson Adjei; Fuseini Mahama; Chrysantus Kubio; Timothy Roberton展开收起
作者单位
1. University of Western Australia; 2. Ghana Health Service; 3. University for Development Studies; 4. London School of Hygiene and Tropical Medicine; 5. International Organisation for Migration; 6. Savelugu Municipal Hospital; 7. WHO Country Office for Ghana展开收起
114
天
A qualitative evaluation of a STEAM (Science, technology, engineering, arts, and mathematics) peer education intervention on teenagers’ knowledge, confidence, and advocacy for HPV vaccine communication
作者
Carol Gray Brunton; Iain Macdonald; Céline Healy; Richard Firth; Alexandra McDermott; Eva Malone展开收起
作者单位
1. Edinburgh Napier University; 2. Maynooth University; 3. Glanbia Business Services展开收起
160
天
62
天
Evaluating a multi-vaccine respiratory immunization strategy involving SARS-CoV-2, pneumococcal, and influenza vaccines in adults: A randomized, open-label, multicenter, controlled, non-inferiority Phase IV trial in China
作者
Xuanwen Shi; Shasha Han; Cong Wu; Xuejuan Wang; Jiao Huang; Wei Chen; Xiaoqin Liu; Sheng Wei; Jun Liu; Xiang Guo; Chenhao Wang; Shengyi Wang; Min Zhang; Xue Guo; Wei Zhao; Haiping Chen; Qingliang Li展开收起
作者单位
1. China National Biotec Group Company Limited; 2. Wuhan Institute of Biological Products Co., Ltd; 3. National Engineering Technology Research Center for Combined Vaccines; 4. Zhongnan Hospital of Wuhan University; 5. National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases; 6. Huazhong University of Science and Technology; 7. Changchun Institute of Biological Products Co., Ltd; 8. Chengdu Institute of Biological Products Co., Ltd展开收起
75
天
FAQ
Human Vaccines & Immunotherapeutics审稿要多久?
截至2026-11-19,CrushSCI 收录了 Human Vaccines & Immunotherapeutics 的 21 篇完整审稿记录。最快一篇从收稿到录用用了 62 天(Evaluating a multi-vaccine respiratory immunization strategy involving SARS-CoV-2, pneumococcal, and influenza vaccines in adults: A randomized, open-label, multicenter, controlled, non-inferiority Phase IV trial in China,2026-08-06 收稿,2026-10-07 录用),最慢一篇用了 189 天;平均 116.0 天,中位数 114 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
